Perceptive Advisors »

Alto Neuroscience shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Alto Neuroscience (ANRO) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Alto Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Alto Neuroscience held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alto Neuroscience by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $625k 155k 4.02

More positions owned by Perceptive Advisors

Rhythm Pharmaceuticals (RYTM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arcellx Common Stock (ACLX)
Celcuity (CELC)
Nuvalent Inc-a (NUVL)
Merus N V (MRUS)
Amylyx Pharmaceuticals (AMLX)
Roivant Sciences SHS (ROIV)
Meiragtx Holdings (MGTX)
Insmed Com Par $.01 (INSM)
Travere Therapeutics (TVTX)
CryoLife (AORT)
Praxis Precision Medicines I Com New (PRAX)
Immatics SHS (IMTX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for Perceptive Advisors

Top funds holding Alto Neuroscience

Falcon Edge Capital
Armistice Capital
Point72 Asset Management
Franklin Resources
Vanguard Group
Vestal Point Capital
Marshall Wace
72 Investment Holdings
Alkeon Capital Management
Northern Trust
Integral Health Asset Management
BlackRock
Millennium Management
Peapod Lane Capital
AWM Investment Company

View all funds holding Alto Neuroscience